Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 81.42 is 805% above its 5-year average of 8.99, near the high end of its 5-year range (4.60–81.42).
As of the fiscal period ended Tuesday, June 30, 2026. 113.43% above its 12-month average of 38.15.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 81.42.
QUICK RATIO (ACID-TEST)
81.42
QUICK RATIO (ACID-TEST) AVG TTM
38.15
QUICK RATIO (ACID-TEST) AVG 3Y
9.83
QUICK RATIO (ACID-TEST) AVG 5Y
8.99
QUICK RATIO (ACID-TEST) AVG 10Y
11.34
QUICK RATIO (ACID-TEST) AVG 15Y
9.75
QUICK RATIO (ACID-TEST) AVG 20Y
8.52
CURRENT VS TTM AVG
+113.43%
CURRENT VS 3Y AVG
+727.86%
CURRENT VS 5Y AVG
+805.27%
CURRENT VS 10Y AVG
+617.72%
CURRENT VS 15Y AVG
+734.71%
CURRENT VS 20Y AVG
+855.53%
SECTOR MEDIAN · HEALTHCARE
3.17
median of 724 covered companies
CURRENT VS SECTOR MEDIAN
+2464.28%
vs the sector median at left
Arbutus Biopharma Corp
Market Cap
$900.79M
Quick Ratio (Acid-Test)
81.42
TTM Avg
38.15
3Y Avg
9.83
5Y Avg
8.99
Market Cap
$898.61M
Quick Ratio (Acid-Test)
1.17
TTM Avg
1.03
3Y Avg
0.92
5Y Avg
1.05
Market Cap
$888.21M
Quick Ratio (Acid-Test)
16.16
TTM Avg
3.88
3Y Avg
3.97
5Y Avg
4.50
Market Cap
$914.32M
Quick Ratio (Acid-Test)
1.06
TTM Avg
1.14
3Y Avg
1.09
5Y Avg
1.06
Market Cap
$877.41M
Quick Ratio (Acid-Test)
1.79
TTM Avg
2.17
3Y Avg
1.93
5Y Avg
2.04
Market Cap
$933.77M
Quick Ratio (Acid-Test)
8.79
TTM Avg
12.77
3Y Avg
8.84
5Y Avg
8.84
Market Cap
$858.40M
Quick Ratio (Acid-Test)
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
Market Cap
$938.53M
Quick Ratio (Acid-Test)
11.36
TTM Avg
7.20
3Y Avg
7.20
5Y Avg
7.20
Market Cap
$948.70M
Quick Ratio (Acid-Test)
12.56
TTM Avg
15.19
3Y Avg
22.99
5Y Avg
17.56
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $900.79M | 81.42 | 38.15 | 9.83 | 8.99 |
| Bioventus Inc. (BVS)vs › | $898.61M | 1.17 | 1.03 | 0.92 | 1.05 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $888.21M | 16.16 | 3.88 | 3.97 | 4.50 |
| HealthStream, Inc. (HSTM)vs › | $914.32M | 1.06 | 1.14 | 1.09 | 1.06 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $877.41M | 1.79 | 2.17 | 1.93 | 2.04 |
| CeriBell, Inc. (CBLL)vs › | $933.77M | 8.79 | 12.77 | 8.84 | 8.84 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $858.40M | 9.52 | 4.26 | 6.09 | 7.80 |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $938.53M | 11.36 | 7.20 | 7.20 | 7.20 |
| MoonLake Immunotherapeutics (MLTX)vs › | $948.70M | 12.56 | 15.19 | 22.99 | 17.56 |
| QuidelOrtho Corporation (QDEL)vs › | $847.61M | 0.76 | 0.79 | 0.88 | 1.73 |
Quick Ratio
81.42
Excludes inventory
Current Ratio
81.42
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 81.42 |
| 2026-03-31 | 54.26 |
| 2025-12-31 | 15.73 |
| 2025-09-30 | 18.80 |
| 2025-06-30 | 20.53 |
| 2025-03-31 | 6.01 |
| 2024-12-31 | 8.15 |
| 2024-09-30 | 7.02 |
| 2024-06-30 | 6.56 |
| 2024-03-31 | 6.69 |
| 2023-12-31 | 5.87 |
| 2023-09-30 | 6.34 |
| 2023-06-30 | 6.47 |
| 2023-03-31 | 6.08 |
| 2022-12-31 | 4.60 |
| 2022-09-30 | 5.13 |
| 2022-06-30 | 5.29 |
| 2022-03-31 | 5.33 |
| 2021-12-31 | 14.32 |
| 2021-09-30 | 12.51 |
| 2021-06-30 | 9.44 |
| 2021-03-31 | 20.52 |
| 2020-12-31 | 13.38 |
| 2020-09-30 | 15.94 |
| 2020-06-30 | 13.52 |
| 2020-03-31 | 21.91 |
| 2019-12-31 | 11.99 |
| 2019-09-30 | 10.70 |
| 2019-06-30 | 11.32 |
| 2019-03-31 | 12.75 |
| 2018-12-31 | 11.50 |
| 2018-09-30 | 11.37 |
| 2018-06-30 | 13.67 |
| 2018-03-31 | 16.85 |
| 2017-12-31 | 8.71 |
| 2017-09-30 | 10.86 |
| 2017-06-30 | 8.79 |
| 2017-03-31 | 10.93 |
| 2016-12-31 | 12.41 |
| 2016-09-30 | 17.93 |
| 2016-06-30 | 16.48 |
| 2016-03-31 | 15.61 |
| 2015-12-31 | 17.28 |
| 2015-09-30 | 14.41 |
| 2015-06-30 | 20.54 |
| 2015-03-31 | 9.65 |
| 2014-12-31 | 5.70 |
| 2014-09-30 | 5.73 |
| 2014-06-30 | 7.19 |
| 2014-03-31 | 5.94 |
| 2013-12-31 | 5.55 |
| 2013-09-30 | 3.10 |
| 2013-06-30 | 3.91 |
| 2013-03-31 | 4.17 |
| 2012-12-31 | 4.68 |
| 2012-09-30 | 0.98 |
| 2012-06-30 | 1.45 |
| 2012-03-31 | 1.64 |
| 2011-12-31 | 1.69 |
| 2011-09-30 | 1.95 |
| 2011-06-30 | 1.89 |
| 2011-03-31 | 1.86 |
| 2010-12-31 | 2.18 |
| 2010-09-30 | 1.91 |
| 2010-06-30 | 2.35 |
| 2010-03-31 | 4.18 |
| 2009-12-31 | 3.81 |
| 2009-09-30 | 4.20 |
| 2009-06-30 | 5.13 |
| 2009-03-31 | 5.73 |
| 2008-12-31 | 6.71 |
| 2008-09-30 | 6.37 |
| 2008-06-30 | 5.04 |
| 2008-03-31 | 4.10 |
| 2007-12-31 | 3.57 |
| 2007-09-30 | 3.51 |
| 2007-06-30 | 2.91 |
